Pioglitazone is used for the treatment of diabetes mellitus type 2. Pioglitazone selectively stimulates nuclear receptor peroxisone proliferator-activated receptor gamma (PPAR-gamma). It modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in the lipidic, muscular tissues and in the liver.

Top Gene Interactions

Related Pathways

General Information


Mechanism of Action

Pioglitazone Interacts with Diseases

Pioglitazone Interacts with Genes